214 related articles for article (PubMed ID: 15298365)
1. Prescribing proton pump inhibitors for initial treatment of acid-related gastrointestinal diseases in a managed care population.
Chan J; Hui RL; Szpakowski JL
Am J Manag Care; 2004 Jul; 10(7 Pt 1):433-41. PubMed ID: 15298365
[TBL] [Abstract][Full Text] [Related]
2. Proton pump inhibitors. Compliance with a mandated step-up program.
Mamdani MM; Tu K; Jaakkimainen L; Bica A; Hux J
Can Fam Physician; 2001 Mar; 47():531-5. PubMed ID: 11281086
[TBL] [Abstract][Full Text] [Related]
3. The extent and determinants of prescribing and adherence with acid-reducing medications: a national claims database study.
El-Serag HB; Fitzgerald S; Richardson P
Am J Gastroenterol; 2009 Sep; 104(9):2161-7. PubMed ID: 19568229
[TBL] [Abstract][Full Text] [Related]
4. A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease.
Gerson LB; Robbins AS; Garber A; Hornberger J; Triadafilopoulos G
Am J Gastroenterol; 2000 Feb; 95(2):395-407. PubMed ID: 10685741
[TBL] [Abstract][Full Text] [Related]
5. Proton pump inhibitors: perspectives of patients and their GPs.
Grime J; Pollock K; Blenkinsopp A
Br J Gen Pract; 2001 Sep; 51(470):703-11. PubMed ID: 11593830
[TBL] [Abstract][Full Text] [Related]
6. A critical evaluation of proton pump inhibitors in the treatment of gastroesophageal reflux disease.
Berardi RR
Am J Manag Care; 2000 May; 6(9 Suppl):S491-505. PubMed ID: 10977489
[TBL] [Abstract][Full Text] [Related]
7. A practice-based approach for converting from proton pump inhibitors to less costly therapy.
Lucas LM; Gerrity MS; Anderson T
Eff Clin Pract; 2001; 4(6):263-70. PubMed ID: 11769299
[TBL] [Abstract][Full Text] [Related]
8. Chronic acid-related disorders are common and underinvestigated.
Majumdar SR; Soumerai SB; Farraye FA; Lee M; Kemp JA; Henning JM; Schrammel P; LeCates RF; Ross-Degnan D
Am J Gastroenterol; 2003 Nov; 98(11):2409-14. PubMed ID: 14638341
[TBL] [Abstract][Full Text] [Related]
9. Proton pump inhibitors and hospital discharge rates for gastrointestinal events in Italy: a national ecological study.
Russo P; Brutti C
Clin Ther; 2007 Apr; 29(4):751-8. PubMed ID: 17617299
[TBL] [Abstract][Full Text] [Related]
10. Cost analysis of a provincial drug program to guide the treatment of upper gastrointestinal disorders.
Bursey F; Crowley M; Janes C; Turner CJ
CMAJ; 2000 Mar; 162(6):817-23. PubMed ID: 10750472
[TBL] [Abstract][Full Text] [Related]
11. Healthcare costs of GERD and acid-related conditions in pediatric patients, with comparison between histamine-2 receptor antagonists and proton pump inhibitors.
Kothari S; Nelson SP; Wu EQ; Beaulieu N; McHale JM; Dabbous OH
Curr Med Res Opin; 2009 Nov; 25(11):2703-9. PubMed ID: 19775195
[TBL] [Abstract][Full Text] [Related]
12. Long-term prescribing of proton pump inhibitors in general practice.
Hungin AP; Rubin GP; O'Flanagan H
Br J Gen Pract; 1999 Jun; 49(443):451-3. PubMed ID: 10562744
[TBL] [Abstract][Full Text] [Related]
13. Proton pump inhibitors prescribing following the introduction of generic drugs.
Cammarota S; Bruzzese D; Sarnelli G; Citarella A; Menditto E; Riegler S; Savino IG; Vozzella L; Piccinocchi G; Napoli L; Arpino G; Cuomo R
Eur J Clin Invest; 2012 Oct; 42(10):1068-78. PubMed ID: 22681176
[TBL] [Abstract][Full Text] [Related]
14. Clinical and financial outcomes associated with a proton pump inhibitor prior-authorization program in a Medicaid population.
Delate T; Mager DE; Sheth J; Motheral BR
Am J Manag Care; 2005 Jan; 11(1):29-36. PubMed ID: 15697098
[TBL] [Abstract][Full Text] [Related]
15. Gastroprotective drugs in Australia: utilization patterns between 1997 and 2006 in relation to NSAID prescribing.
Barozzi N; Tett SE
Clin Ther; 2009 Apr; 31(4):849-61. PubMed ID: 19446158
[TBL] [Abstract][Full Text] [Related]
16. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.
Canani RB; Cirillo P; Roggero P; Romano C; Malamisura B; Terrin G; Passariello A; Manguso F; Morelli L; Guarino A;
Pediatrics; 2006 May; 117(5):e817-20. PubMed ID: 16651285
[TBL] [Abstract][Full Text] [Related]
17. Lansoprazole overutilization: methods for step-down therapy.
Pohland CJ; Scavnicky SA; Lasky SS; Good CB
Am J Manag Care; 2003 May; 9(5):353-8. PubMed ID: 12744297
[TBL] [Abstract][Full Text] [Related]
18. Large variations in prescriptions of gastrointestinal medications in hemodialysis patients on three continents: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
Bailie GR; Mason NA; Elder SJ; Andreucci VE; Greenwood RN; Akiba T; Saito A; Bragg-Gresham JL; Gillespie BW; Young EW
Hemodial Int; 2006 Apr; 10(2):180-8. PubMed ID: 16623672
[TBL] [Abstract][Full Text] [Related]
19. A randomized trial of an acid-peptic disease management program in a managed care environment.
Ofman JJ; Segal R; Russell WL; Cook DJ; Sandhu M; Maue SK; Lowenstein EH; Pourfarzib R; Blanchette E; Ellrodt G; Weingarten SR
Am J Manag Care; 2003 Jun; 9(6):425-33. PubMed ID: 12816172
[TBL] [Abstract][Full Text] [Related]
20. Differences in the diagnostic yield of upper gastrointestinal endoscopy in dyspeptic patients receiving proton-pump inhibitors and H2-receptor antagonists.
Mitchell RM; Collins JS; Watson RG; Tham TC
Endoscopy; 2002 Jul; 34(7):524-6. PubMed ID: 12170401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
